Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.74 USD | -3.10% | -7.82% | -27.31% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.31% | 8.21B | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Scotiabank Upgrades Legend Biotech to Sector Outperform From Sector Perform, Price Target is $65